Lung Non-Squamous Non-Small Cell Carcinoma

9 clinical trials · Condition

Record	Firm	Date
Evaluating Modifiable Biomarkers for the Prediction of Immunotherapy Response and Toxicity (NCT04954885)	Ohio State University Comprehensive Cancer Center	2021-05-18
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO]) (NCT04267848)	National Cancer Institute (NCI)	2020-06-16
Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer (NCT03737994)	National Cancer Institute (NCI)	2019-07-25
Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer (NCT03793179)	National Cancer Institute (NCI)	2019-04-05
Nintedanib Compared With Placebo in Treating Against Radiation-Induced Pneumonitis in Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery and Are Undergoing Chemoradiation Therapy (NCT02452463)	Roswell Park Cancer Institute	2015-06-29
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial) (NCT02193282)	National Cancer Institute (NCI)	2015-02-11
Erlotinib Hydrochloride With or Without Bevacizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations (NCT01532089)	Academic and Community Cancer Research United	2012-03-16

Every clearance here is in the API, with alerts when new ones post.